Treatment of acute myeloid leukemia models by targeting a cell surface RNA-binding protein Article Swipe
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1038/s41587-025-02648-2
Immunotherapies for acute myeloid leukemia (AML) and other cancers are limited by a lack of tumor-specific targets. Here we discover that RNA-binding proteins and glycosylated RNAs (glycoRNAs) form precisely organized nanodomains on cancer cell surfaces. We characterize nucleophosmin (NPM1) as an abundant cell surface protein (csNPM1) on a variety of tumor types. With a focus on AML, we observe csNPM1 on blasts and leukemic stem cells but not on normal hematopoietic stem cells. We develop a monoclonal antibody to target csNPM1, which exhibits robust anti-tumor activity in multiple syngeneic and xenograft models of AML, including patient-derived xenografts, without observable toxicity. We find that csNPM1 is expressed in a mutation-agnostic manner on primary AML cells and may therefore offer a general strategy for detecting and treating AML. Surface profiling and in vivo work also demonstrate csNPM1 as a target on solid tumors. Our data suggest that csNPM1 and its neighboring glycoRNA–cell surface RNA-binding protein (csRBP) clusters may serve as an alternative antigen class for therapeutic targeting or cell identification.
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1038/s41587-025-02648-2
- https://www.nature.com/articles/s41587-025-02648-2.pdf
- OA Status
- hybrid
- Cited By
- 8
- References
- 67
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4409704822
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4409704822Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1038/s41587-025-02648-2Digital Object Identifier
- Title
-
Treatment of acute myeloid leukemia models by targeting a cell surface RNA-binding proteinWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-04-23Full publication date if available
- Authors
-
Benson M. George, Maria Eleftheriou, Eliza Yankova, Jonathan Perr, Peiyuan Chai, Gianluca Nestola, Karim Almahayni, Siân Evans, Aristi Damaskou, Helena Hemberger, Charlotta G. Lebedenko, Justyna Rak, Qi Yu, Ece Bapcum, James Russell, Jaana Bagri, Regan Volk, Malte Spiekermann, Richard M. Stone, George Giotopoulos, Brian J.P. Huntly, E. Joanna Baxter, Fernando D. Camargo, Jie Liu, Balyn W. Zaro, George S. Vassiliou, Leonhard Möckl, Jorge de la Rosa, Ryan A. Flynn, Konstantinos TzelepisList of authors in order
- Landing page
-
https://doi.org/10.1038/s41587-025-02648-2Publisher landing page
- PDF URL
-
https://www.nature.com/articles/s41587-025-02648-2.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://www.nature.com/articles/s41587-025-02648-2.pdfDirect OA link when available
- Concepts
-
NPM1, Myeloid leukemia, Cancer research, Haematopoiesis, RNA, Leukemia, Monoclonal antibody, Myeloid, Biology, Stem cell, Antibody, Immunology, Cell biology, Gene, Biochemistry, Karyotype, ChromosomeTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
8Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 8Per-year citation counts (last 5 years)
- References (count)
-
67Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4409704822 |
|---|---|
| doi | https://doi.org/10.1038/s41587-025-02648-2 |
| ids.doi | https://doi.org/10.1038/s41587-025-02648-2 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/40269321 |
| ids.openalex | https://openalex.org/W4409704822 |
| fwci | 21.46355703 |
| type | article |
| title | Treatment of acute myeloid leukemia models by targeting a cell surface RNA-binding protein |
| awards[0].id | https://openalex.org/G6235975807 |
| awards[0].funder_id | https://openalex.org/F4320306271 |
| awards[0].display_name | |
| awards[0].funder_award_id | #74-23 |
| awards[0].funder_display_name | Damon Runyon Cancer Research Foundation |
| awards[1].id | https://openalex.org/G2134177267 |
| awards[1].funder_id | https://openalex.org/F4320307874 |
| awards[1].display_name | |
| awards[1].funder_award_id | RG94424 |
| awards[1].funder_display_name | Wellcome |
| awards[2].id | https://openalex.org/G1548109545 |
| awards[2].funder_id | https://openalex.org/F4320307874 |
| awards[2].display_name | |
| awards[2].funder_award_id | RG106133 |
| awards[2].funder_display_name | Wellcome |
| awards[3].id | https://openalex.org/G6617228231 |
| awards[3].funder_id | https://openalex.org/F4320307874 |
| awards[3].display_name | |
| awards[3].funder_award_id | RG83195 |
| awards[3].funder_display_name | Wellcome |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| grants[0].funder | https://openalex.org/F4320306133 |
| grants[0].award_id | |
| grants[0].funder_display_name | Burroughs Wellcome Fund |
| grants[1].funder | https://openalex.org/F4320306271 |
| grants[1].award_id | #74-23 |
| grants[1].funder_display_name | Damon Runyon Cancer Research Foundation |
| grants[2].funder | https://openalex.org/F4320307874 |
| grants[2].award_id | RG106133 |
| grants[2].funder_display_name | Wellcome |
| grants[3].funder | https://openalex.org/F4320307874 |
| grants[3].award_id | RG83195 |
| grants[3].funder_display_name | Wellcome |
| grants[4].funder | https://openalex.org/F4320307874 |
| grants[4].award_id | RG94424 |
| grants[4].funder_display_name | Wellcome |
| grants[5].funder | https://openalex.org/F4320308911 |
| grants[5].award_id | |
| grants[5].funder_display_name | Sontag Foundation |
| grants[6].funder | https://openalex.org/F4320322434 |
| grants[6].award_id | |
| grants[6].funder_display_name | Max-Planck-Gesellschaft |
| topics[0].id | https://openalex.org/T10725 |
| topics[0].field.id | https://openalex.org/fields/13 |
| topics[0].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[0].score | 0.9994000196456909 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1312 |
| topics[0].subfield.display_name | Molecular Biology |
| topics[0].display_name | RNA Interference and Gene Delivery |
| topics[1].id | https://openalex.org/T10604 |
| topics[1].field.id | https://openalex.org/fields/13 |
| topics[1].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[1].score | 0.9988999962806702 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1312 |
| topics[1].subfield.display_name | Molecular Biology |
| topics[1].display_name | RNA Research and Splicing |
| topics[2].id | https://openalex.org/T10309 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9986000061035156 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2720 |
| topics[2].subfield.display_name | Hematology |
| topics[2].display_name | Acute Myeloid Leukemia Research |
| funders[0].id | https://openalex.org/F4320306133 |
| funders[0].ror | https://ror.org/01d35cw23 |
| funders[0].display_name | Burroughs Wellcome Fund |
| funders[1].id | https://openalex.org/F4320306271 |
| funders[1].ror | https://ror.org/01gd7b947 |
| funders[1].display_name | Damon Runyon Cancer Research Foundation |
| funders[2].id | https://openalex.org/F4320307874 |
| funders[2].ror | https://ror.org/029chgv08 |
| funders[2].display_name | Wellcome |
| funders[3].id | https://openalex.org/F4320308911 |
| funders[3].ror | https://ror.org/01pkpj777 |
| funders[3].display_name | Sontag Foundation |
| funders[4].id | https://openalex.org/F4320322434 |
| funders[4].ror | https://ror.org/01hhn8329 |
| funders[4].display_name | Max-Planck-Gesellschaft |
| is_xpac | False |
| apc_list.value | 9750 |
| apc_list.currency | EUR |
| apc_list.value_usd | 11690 |
| apc_paid.value | 9750 |
| apc_paid.currency | EUR |
| apc_paid.value_usd | 11690 |
| concepts[0].id | https://openalex.org/C2483381 |
| concepts[0].level | 5 |
| concepts[0].score | 0.708582878112793 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q18030194 |
| concepts[0].display_name | NPM1 |
| concepts[1].id | https://openalex.org/C2778729363 |
| concepts[1].level | 2 |
| concepts[1].score | 0.7074183225631714 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11688946 |
| concepts[1].display_name | Myeloid leukemia |
| concepts[2].id | https://openalex.org/C502942594 |
| concepts[2].level | 1 |
| concepts[2].score | 0.6119174957275391 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[2].display_name | Cancer research |
| concepts[3].id | https://openalex.org/C109159458 |
| concepts[3].level | 3 |
| concepts[3].score | 0.5156258940696716 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q919283 |
| concepts[3].display_name | Haematopoiesis |
| concepts[4].id | https://openalex.org/C67705224 |
| concepts[4].level | 3 |
| concepts[4].score | 0.49868249893188477 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q11053 |
| concepts[4].display_name | RNA |
| concepts[5].id | https://openalex.org/C2778461978 |
| concepts[5].level | 2 |
| concepts[5].score | 0.4848100244998932 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q29496 |
| concepts[5].display_name | Leukemia |
| concepts[6].id | https://openalex.org/C542903549 |
| concepts[6].level | 3 |
| concepts[6].score | 0.47579869627952576 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q422248 |
| concepts[6].display_name | Monoclonal antibody |
| concepts[7].id | https://openalex.org/C2779282312 |
| concepts[7].level | 2 |
| concepts[7].score | 0.4458228647708893 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q1956561 |
| concepts[7].display_name | Myeloid |
| concepts[8].id | https://openalex.org/C86803240 |
| concepts[8].level | 0 |
| concepts[8].score | 0.4431847929954529 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[8].display_name | Biology |
| concepts[9].id | https://openalex.org/C28328180 |
| concepts[9].level | 2 |
| concepts[9].score | 0.4051584303379059 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q48196 |
| concepts[9].display_name | Stem cell |
| concepts[10].id | https://openalex.org/C159654299 |
| concepts[10].level | 2 |
| concepts[10].score | 0.31637030839920044 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q79460 |
| concepts[10].display_name | Antibody |
| concepts[11].id | https://openalex.org/C203014093 |
| concepts[11].level | 1 |
| concepts[11].score | 0.238912433385849 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[11].display_name | Immunology |
| concepts[12].id | https://openalex.org/C95444343 |
| concepts[12].level | 1 |
| concepts[12].score | 0.16084545850753784 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q7141 |
| concepts[12].display_name | Cell biology |
| concepts[13].id | https://openalex.org/C104317684 |
| concepts[13].level | 2 |
| concepts[13].score | 0.1351238191127777 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q7187 |
| concepts[13].display_name | Gene |
| concepts[14].id | https://openalex.org/C55493867 |
| concepts[14].level | 1 |
| concepts[14].score | 0.07975497841835022 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[14].display_name | Biochemistry |
| concepts[15].id | https://openalex.org/C53226629 |
| concepts[15].level | 4 |
| concepts[15].score | 0.0 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q189967 |
| concepts[15].display_name | Karyotype |
| concepts[16].id | https://openalex.org/C30481170 |
| concepts[16].level | 3 |
| concepts[16].score | 0.0 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q37748 |
| concepts[16].display_name | Chromosome |
| keywords[0].id | https://openalex.org/keywords/npm1 |
| keywords[0].score | 0.708582878112793 |
| keywords[0].display_name | NPM1 |
| keywords[1].id | https://openalex.org/keywords/myeloid-leukemia |
| keywords[1].score | 0.7074183225631714 |
| keywords[1].display_name | Myeloid leukemia |
| keywords[2].id | https://openalex.org/keywords/cancer-research |
| keywords[2].score | 0.6119174957275391 |
| keywords[2].display_name | Cancer research |
| keywords[3].id | https://openalex.org/keywords/haematopoiesis |
| keywords[3].score | 0.5156258940696716 |
| keywords[3].display_name | Haematopoiesis |
| keywords[4].id | https://openalex.org/keywords/rna |
| keywords[4].score | 0.49868249893188477 |
| keywords[4].display_name | RNA |
| keywords[5].id | https://openalex.org/keywords/leukemia |
| keywords[5].score | 0.4848100244998932 |
| keywords[5].display_name | Leukemia |
| keywords[6].id | https://openalex.org/keywords/monoclonal-antibody |
| keywords[6].score | 0.47579869627952576 |
| keywords[6].display_name | Monoclonal antibody |
| keywords[7].id | https://openalex.org/keywords/myeloid |
| keywords[7].score | 0.4458228647708893 |
| keywords[7].display_name | Myeloid |
| keywords[8].id | https://openalex.org/keywords/biology |
| keywords[8].score | 0.4431847929954529 |
| keywords[8].display_name | Biology |
| keywords[9].id | https://openalex.org/keywords/stem-cell |
| keywords[9].score | 0.4051584303379059 |
| keywords[9].display_name | Stem cell |
| keywords[10].id | https://openalex.org/keywords/antibody |
| keywords[10].score | 0.31637030839920044 |
| keywords[10].display_name | Antibody |
| keywords[11].id | https://openalex.org/keywords/immunology |
| keywords[11].score | 0.238912433385849 |
| keywords[11].display_name | Immunology |
| keywords[12].id | https://openalex.org/keywords/cell-biology |
| keywords[12].score | 0.16084545850753784 |
| keywords[12].display_name | Cell biology |
| keywords[13].id | https://openalex.org/keywords/gene |
| keywords[13].score | 0.1351238191127777 |
| keywords[13].display_name | Gene |
| keywords[14].id | https://openalex.org/keywords/biochemistry |
| keywords[14].score | 0.07975497841835022 |
| keywords[14].display_name | Biochemistry |
| language | en |
| locations[0].id | doi:10.1038/s41587-025-02648-2 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S106963461 |
| locations[0].source.issn | 1087-0156, 1546-1696 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 1087-0156 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Nature Biotechnology |
| locations[0].source.host_organization | https://openalex.org/P4310319908 |
| locations[0].source.host_organization_name | Nature Portfolio |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310319908, https://openalex.org/P4310319965 |
| locations[0].source.host_organization_lineage_names | Nature Portfolio, Springer Nature |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.nature.com/articles/s41587-025-02648-2.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Nature Biotechnology |
| locations[0].landing_page_url | https://doi.org/10.1038/s41587-025-02648-2 |
| locations[1].id | pmid:40269321 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Nature biotechnology |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/40269321 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5060533219 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-4031-0954 |
| authorships[0].author.display_name | Benson M. George |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I1288882113 |
| authorships[0].affiliations[0].raw_affiliation_string | Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA. |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I4210117453 |
| authorships[0].affiliations[1].raw_affiliation_string | Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. |
| authorships[0].institutions[0].id | https://openalex.org/I1288882113 |
| authorships[0].institutions[0].ror | https://ror.org/00dvg7y05 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I1288882113 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | Boston Children's Hospital |
| authorships[0].institutions[1].id | https://openalex.org/I4210117453 |
| authorships[0].institutions[1].ror | https://ror.org/02jzgtq86 |
| authorships[0].institutions[1].type | facility |
| authorships[0].institutions[1].lineage | https://openalex.org/I4210117453 |
| authorships[0].institutions[1].country_code | US |
| authorships[0].institutions[1].display_name | Dana-Farber Cancer Institute |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Benson M George |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA. |
| authorships[1].author.id | https://openalex.org/A5101830455 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-1842-5838 |
| authorships[1].author.display_name | Maria Eleftheriou |
| authorships[1].countries | GB |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I241749 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Haematology, University of Cambridge, Cambridge, UK. |
| authorships[1].affiliations[1].institution_ids | https://openalex.org/I21196054, https://openalex.org/I241749 |
| authorships[1].affiliations[1].raw_affiliation_string | Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK. |
| authorships[1].affiliations[2].institution_ids | https://openalex.org/I241749 |
| authorships[1].affiliations[2].raw_affiliation_string | Milner Therapeutics Institute, University of Cambridge, Cambridge, UK. |
| authorships[1].institutions[0].id | https://openalex.org/I241749 |
| authorships[1].institutions[0].ror | https://ror.org/013meh722 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I241749 |
| authorships[1].institutions[0].country_code | GB |
| authorships[1].institutions[0].display_name | University of Cambridge |
| authorships[1].institutions[1].id | https://openalex.org/I21196054 |
| authorships[1].institutions[1].ror | https://ror.org/05nz0zp31 |
| authorships[1].institutions[1].type | facility |
| authorships[1].institutions[1].lineage | https://openalex.org/I21196054, https://openalex.org/I241749, https://openalex.org/I4210087105, https://openalex.org/I87048295, https://openalex.org/I90344618 |
| authorships[1].institutions[1].country_code | GB |
| authorships[1].institutions[1].display_name | Wellcome/MRC Cambridge Stem Cell Institute |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Maria Eleftheriou |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Department of Haematology, University of Cambridge, Cambridge, UK., Milner Therapeutics Institute, University of Cambridge, Cambridge, UK. |
| authorships[2].author.id | https://openalex.org/A5058603994 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-2913-0012 |
| authorships[2].author.display_name | Eliza Yankova |
| authorships[2].countries | GB |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I241749 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Haematology, University of Cambridge, Cambridge, UK. |
| authorships[2].affiliations[1].institution_ids | https://openalex.org/I241749 |
| authorships[2].affiliations[1].raw_affiliation_string | Milner Therapeutics Institute, University of Cambridge, Cambridge, UK. |
| authorships[2].affiliations[2].institution_ids | https://openalex.org/I21196054, https://openalex.org/I241749 |
| authorships[2].affiliations[2].raw_affiliation_string | Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK. |
| authorships[2].institutions[0].id | https://openalex.org/I241749 |
| authorships[2].institutions[0].ror | https://ror.org/013meh722 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I241749 |
| authorships[2].institutions[0].country_code | GB |
| authorships[2].institutions[0].display_name | University of Cambridge |
| authorships[2].institutions[1].id | https://openalex.org/I21196054 |
| authorships[2].institutions[1].ror | https://ror.org/05nz0zp31 |
| authorships[2].institutions[1].type | facility |
| authorships[2].institutions[1].lineage | https://openalex.org/I21196054, https://openalex.org/I241749, https://openalex.org/I4210087105, https://openalex.org/I87048295, https://openalex.org/I90344618 |
| authorships[2].institutions[1].country_code | GB |
| authorships[2].institutions[1].display_name | Wellcome/MRC Cambridge Stem Cell Institute |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Eliza Yankova |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Department of Haematology, University of Cambridge, Cambridge, UK., Milner Therapeutics Institute, University of Cambridge, Cambridge, UK. |
| authorships[3].author.id | https://openalex.org/A5040990016 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-0014-2565 |
| authorships[3].author.display_name | Jonathan Perr |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I1288882113 |
| authorships[3].affiliations[0].raw_affiliation_string | Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA. |
| authorships[3].institutions[0].id | https://openalex.org/I1288882113 |
| authorships[3].institutions[0].ror | https://ror.org/00dvg7y05 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I1288882113 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | Boston Children's Hospital |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Jonathan Perr |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA. |
| authorships[4].author.id | https://openalex.org/A5019503696 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-9203-8975 |
| authorships[4].author.display_name | Peiyuan Chai |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I1288882113 |
| authorships[4].affiliations[0].raw_affiliation_string | Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA. |
| authorships[4].institutions[0].id | https://openalex.org/I1288882113 |
| authorships[4].institutions[0].ror | https://ror.org/00dvg7y05 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I1288882113 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | Boston Children's Hospital |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Peiyuan Chai |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA. |
| authorships[5].author.id | https://openalex.org/A5091920876 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Gianluca Nestola |
| authorships[5].countries | DE |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I181369854 |
| authorships[5].affiliations[0].raw_affiliation_string | Department of Physics, Friedrich-Alexander University of Erlangen-Nuremberg, Erlangen, Germany. |
| authorships[5].institutions[0].id | https://openalex.org/I181369854 |
| authorships[5].institutions[0].ror | https://ror.org/00f7hpc57 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I181369854 |
| authorships[5].institutions[0].country_code | DE |
| authorships[5].institutions[0].display_name | Friedrich-Alexander-Universität Erlangen-Nürnberg |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Gianluca Nestola |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Department of Physics, Friedrich-Alexander University of Erlangen-Nuremberg, Erlangen, Germany. |
| authorships[6].author.id | https://openalex.org/A5065021815 |
| authorships[6].author.orcid | https://orcid.org/0000-0001-6844-4327 |
| authorships[6].author.display_name | Karim Almahayni |
| authorships[6].countries | DE |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I181369854 |
| authorships[6].affiliations[0].raw_affiliation_string | Department of Physics, Friedrich-Alexander University of Erlangen-Nuremberg, Erlangen, Germany. |
| authorships[6].affiliations[1].institution_ids | https://openalex.org/I4210110240 |
| authorships[6].affiliations[1].raw_affiliation_string | Max Planck Institute for the Science of Light, Erlangen, Germany. |
| authorships[6].institutions[0].id | https://openalex.org/I181369854 |
| authorships[6].institutions[0].ror | https://ror.org/00f7hpc57 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I181369854 |
| authorships[6].institutions[0].country_code | DE |
| authorships[6].institutions[0].display_name | Friedrich-Alexander-Universität Erlangen-Nürnberg |
| authorships[6].institutions[1].id | https://openalex.org/I4210110240 |
| authorships[6].institutions[1].ror | https://ror.org/020as7681 |
| authorships[6].institutions[1].type | facility |
| authorships[6].institutions[1].lineage | https://openalex.org/I149899117, https://openalex.org/I4210110240 |
| authorships[6].institutions[1].country_code | DE |
| authorships[6].institutions[1].display_name | Max Planck Institute for the Science of Light |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Karim Almahayni |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Department of Physics, Friedrich-Alexander University of Erlangen-Nuremberg, Erlangen, Germany., Max Planck Institute for the Science of Light, Erlangen, Germany. |
| authorships[7].author.id | https://openalex.org/A5069106679 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-2867-1688 |
| authorships[7].author.display_name | Siân Evans |
| authorships[7].countries | GB |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I21196054, https://openalex.org/I241749 |
| authorships[7].affiliations[0].raw_affiliation_string | Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK. |
| authorships[7].affiliations[1].institution_ids | https://openalex.org/I241749 |
| authorships[7].affiliations[1].raw_affiliation_string | Department of Haematology, University of Cambridge, Cambridge, UK. |
| authorships[7].institutions[0].id | https://openalex.org/I241749 |
| authorships[7].institutions[0].ror | https://ror.org/013meh722 |
| authorships[7].institutions[0].type | education |
| authorships[7].institutions[0].lineage | https://openalex.org/I241749 |
| authorships[7].institutions[0].country_code | GB |
| authorships[7].institutions[0].display_name | University of Cambridge |
| authorships[7].institutions[1].id | https://openalex.org/I21196054 |
| authorships[7].institutions[1].ror | https://ror.org/05nz0zp31 |
| authorships[7].institutions[1].type | facility |
| authorships[7].institutions[1].lineage | https://openalex.org/I21196054, https://openalex.org/I241749, https://openalex.org/I4210087105, https://openalex.org/I87048295, https://openalex.org/I90344618 |
| authorships[7].institutions[1].country_code | GB |
| authorships[7].institutions[1].display_name | Wellcome/MRC Cambridge Stem Cell Institute |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Siân Evans |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Department of Haematology, University of Cambridge, Cambridge, UK. |
| authorships[8].author.id | https://openalex.org/A5041603867 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Aristi Damaskou |
| authorships[8].countries | GB |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I241749 |
| authorships[8].affiliations[0].raw_affiliation_string | Department of Haematology, University of Cambridge, Cambridge, UK. |
| authorships[8].affiliations[1].institution_ids | https://openalex.org/I21196054, https://openalex.org/I241749 |
| authorships[8].affiliations[1].raw_affiliation_string | Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK. |
| authorships[8].institutions[0].id | https://openalex.org/I241749 |
| authorships[8].institutions[0].ror | https://ror.org/013meh722 |
| authorships[8].institutions[0].type | education |
| authorships[8].institutions[0].lineage | https://openalex.org/I241749 |
| authorships[8].institutions[0].country_code | GB |
| authorships[8].institutions[0].display_name | University of Cambridge |
| authorships[8].institutions[1].id | https://openalex.org/I21196054 |
| authorships[8].institutions[1].ror | https://ror.org/05nz0zp31 |
| authorships[8].institutions[1].type | facility |
| authorships[8].institutions[1].lineage | https://openalex.org/I21196054, https://openalex.org/I241749, https://openalex.org/I4210087105, https://openalex.org/I87048295, https://openalex.org/I90344618 |
| authorships[8].institutions[1].country_code | GB |
| authorships[8].institutions[1].display_name | Wellcome/MRC Cambridge Stem Cell Institute |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Aristi Damaskou |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Department of Haematology, University of Cambridge, Cambridge, UK. |
| authorships[9].author.id | https://openalex.org/A5034135536 |
| authorships[9].author.orcid | https://orcid.org/0009-0007-4535-5859 |
| authorships[9].author.display_name | Helena Hemberger |
| authorships[9].countries | US |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I1288882113 |
| authorships[9].affiliations[0].raw_affiliation_string | Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA. |
| authorships[9].institutions[0].id | https://openalex.org/I1288882113 |
| authorships[9].institutions[0].ror | https://ror.org/00dvg7y05 |
| authorships[9].institutions[0].type | healthcare |
| authorships[9].institutions[0].lineage | https://openalex.org/I1288882113 |
| authorships[9].institutions[0].country_code | US |
| authorships[9].institutions[0].display_name | Boston Children's Hospital |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Helena Hemberger |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA. |
| authorships[10].author.id | https://openalex.org/A5003109718 |
| authorships[10].author.orcid | https://orcid.org/0000-0002-9891-9247 |
| authorships[10].author.display_name | Charlotta G. Lebedenko |
| authorships[10].countries | US |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I1288882113 |
| authorships[10].affiliations[0].raw_affiliation_string | Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA. |
| authorships[10].institutions[0].id | https://openalex.org/I1288882113 |
| authorships[10].institutions[0].ror | https://ror.org/00dvg7y05 |
| authorships[10].institutions[0].type | healthcare |
| authorships[10].institutions[0].lineage | https://openalex.org/I1288882113 |
| authorships[10].institutions[0].country_code | US |
| authorships[10].institutions[0].display_name | Boston Children's Hospital |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Charlotta G Lebedenko |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA. |
| authorships[11].author.id | https://openalex.org/A5043345855 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-9398-4947 |
| authorships[11].author.display_name | Justyna Rak |
| authorships[11].countries | GB |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I241749 |
| authorships[11].affiliations[0].raw_affiliation_string | Department of Haematology, University of Cambridge, Cambridge, UK. |
| authorships[11].affiliations[1].institution_ids | https://openalex.org/I21196054, https://openalex.org/I241749 |
| authorships[11].affiliations[1].raw_affiliation_string | Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK. |
| authorships[11].institutions[0].id | https://openalex.org/I241749 |
| authorships[11].institutions[0].ror | https://ror.org/013meh722 |
| authorships[11].institutions[0].type | education |
| authorships[11].institutions[0].lineage | https://openalex.org/I241749 |
| authorships[11].institutions[0].country_code | GB |
| authorships[11].institutions[0].display_name | University of Cambridge |
| authorships[11].institutions[1].id | https://openalex.org/I21196054 |
| authorships[11].institutions[1].ror | https://ror.org/05nz0zp31 |
| authorships[11].institutions[1].type | facility |
| authorships[11].institutions[1].lineage | https://openalex.org/I21196054, https://openalex.org/I241749, https://openalex.org/I4210087105, https://openalex.org/I87048295, https://openalex.org/I90344618 |
| authorships[11].institutions[1].country_code | GB |
| authorships[11].institutions[1].display_name | Wellcome/MRC Cambridge Stem Cell Institute |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Justyna Rak |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Department of Haematology, University of Cambridge, Cambridge, UK. |
| authorships[12].author.id | https://openalex.org/A5103287247 |
| authorships[12].author.orcid | |
| authorships[12].author.display_name | Qi Yu |
| authorships[12].countries | US |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I1288882113 |
| authorships[12].affiliations[0].raw_affiliation_string | Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA. |
| authorships[12].institutions[0].id | https://openalex.org/I1288882113 |
| authorships[12].institutions[0].ror | https://ror.org/00dvg7y05 |
| authorships[12].institutions[0].type | healthcare |
| authorships[12].institutions[0].lineage | https://openalex.org/I1288882113 |
| authorships[12].institutions[0].country_code | US |
| authorships[12].institutions[0].display_name | Boston Children's Hospital |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Qi Yu |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA. |
| authorships[13].author.id | https://openalex.org/A5117265264 |
| authorships[13].author.orcid | |
| authorships[13].author.display_name | Ece Bapcum |
| authorships[13].countries | US |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I1288882113 |
| authorships[13].affiliations[0].raw_affiliation_string | Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA. |
| authorships[13].institutions[0].id | https://openalex.org/I1288882113 |
| authorships[13].institutions[0].ror | https://ror.org/00dvg7y05 |
| authorships[13].institutions[0].type | healthcare |
| authorships[13].institutions[0].lineage | https://openalex.org/I1288882113 |
| authorships[13].institutions[0].country_code | US |
| authorships[13].institutions[0].display_name | Boston Children's Hospital |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Ece Bapcum |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA. |
| authorships[14].author.id | https://openalex.org/A5081122792 |
| authorships[14].author.orcid | https://orcid.org/0000-0002-9431-8428 |
| authorships[14].author.display_name | James Russell |
| authorships[14].countries | GB |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I241749 |
| authorships[14].affiliations[0].raw_affiliation_string | Department of Haematology, University of Cambridge, Cambridge, UK. |
| authorships[14].affiliations[1].institution_ids | https://openalex.org/I21196054, https://openalex.org/I241749 |
| authorships[14].affiliations[1].raw_affiliation_string | Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK. |
| authorships[14].institutions[0].id | https://openalex.org/I241749 |
| authorships[14].institutions[0].ror | https://ror.org/013meh722 |
| authorships[14].institutions[0].type | education |
| authorships[14].institutions[0].lineage | https://openalex.org/I241749 |
| authorships[14].institutions[0].country_code | GB |
| authorships[14].institutions[0].display_name | University of Cambridge |
| authorships[14].institutions[1].id | https://openalex.org/I21196054 |
| authorships[14].institutions[1].ror | https://ror.org/05nz0zp31 |
| authorships[14].institutions[1].type | facility |
| authorships[14].institutions[1].lineage | https://openalex.org/I21196054, https://openalex.org/I241749, https://openalex.org/I4210087105, https://openalex.org/I87048295, https://openalex.org/I90344618 |
| authorships[14].institutions[1].country_code | GB |
| authorships[14].institutions[1].display_name | Wellcome/MRC Cambridge Stem Cell Institute |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | James Russell |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Department of Haematology, University of Cambridge, Cambridge, UK. |
| authorships[15].author.id | https://openalex.org/A5040733979 |
| authorships[15].author.orcid | https://orcid.org/0000-0002-2450-8226 |
| authorships[15].author.display_name | Jaana Bagri |
| authorships[15].countries | GB |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I241749 |
| authorships[15].affiliations[0].raw_affiliation_string | Department of Haematology, University of Cambridge, Cambridge, UK. |
| authorships[15].affiliations[1].institution_ids | https://openalex.org/I21196054, https://openalex.org/I241749 |
| authorships[15].affiliations[1].raw_affiliation_string | Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK. |
| authorships[15].institutions[0].id | https://openalex.org/I241749 |
| authorships[15].institutions[0].ror | https://ror.org/013meh722 |
| authorships[15].institutions[0].type | education |
| authorships[15].institutions[0].lineage | https://openalex.org/I241749 |
| authorships[15].institutions[0].country_code | GB |
| authorships[15].institutions[0].display_name | University of Cambridge |
| authorships[15].institutions[1].id | https://openalex.org/I21196054 |
| authorships[15].institutions[1].ror | https://ror.org/05nz0zp31 |
| authorships[15].institutions[1].type | facility |
| authorships[15].institutions[1].lineage | https://openalex.org/I21196054, https://openalex.org/I241749, https://openalex.org/I4210087105, https://openalex.org/I87048295, https://openalex.org/I90344618 |
| authorships[15].institutions[1].country_code | GB |
| authorships[15].institutions[1].display_name | Wellcome/MRC Cambridge Stem Cell Institute |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Jaana Bagri |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Department of Haematology, University of Cambridge, Cambridge, UK. |
| authorships[16].author.id | https://openalex.org/A5019889816 |
| authorships[16].author.orcid | https://orcid.org/0000-0001-6748-719X |
| authorships[16].author.display_name | Regan Volk |
| authorships[16].countries | US |
| authorships[16].affiliations[0].institution_ids | https://openalex.org/I180670191 |
| authorships[16].affiliations[0].raw_affiliation_string | Department of Pharmaceutical Chemistry, Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA, USA. |
| authorships[16].institutions[0].id | https://openalex.org/I180670191 |
| authorships[16].institutions[0].ror | https://ror.org/043mz5j54 |
| authorships[16].institutions[0].type | education |
| authorships[16].institutions[0].lineage | https://openalex.org/I180670191 |
| authorships[16].institutions[0].country_code | US |
| authorships[16].institutions[0].display_name | University of California, San Francisco |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Regan F Volk |
| authorships[16].is_corresponding | False |
| authorships[16].raw_affiliation_strings | Department of Pharmaceutical Chemistry, Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA, USA. |
| authorships[17].author.id | https://openalex.org/A5028813046 |
| authorships[17].author.orcid | https://orcid.org/0000-0001-5760-9333 |
| authorships[17].author.display_name | Malte Spiekermann |
| authorships[17].countries | DE |
| authorships[17].affiliations[0].institution_ids | https://openalex.org/I4210110240 |
| authorships[17].affiliations[0].raw_affiliation_string | Max Planck Institute for the Science of Light, Erlangen, Germany. |
| authorships[17].institutions[0].id | https://openalex.org/I4210110240 |
| authorships[17].institutions[0].ror | https://ror.org/020as7681 |
| authorships[17].institutions[0].type | facility |
| authorships[17].institutions[0].lineage | https://openalex.org/I149899117, https://openalex.org/I4210110240 |
| authorships[17].institutions[0].country_code | DE |
| authorships[17].institutions[0].display_name | Max Planck Institute for the Science of Light |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Malte Spiekermann |
| authorships[17].is_corresponding | False |
| authorships[17].raw_affiliation_strings | Max Planck Institute for the Science of Light, Erlangen, Germany. |
| authorships[18].author.id | https://openalex.org/A5071023119 |
| authorships[18].author.orcid | https://orcid.org/0000-0002-7526-2633 |
| authorships[18].author.display_name | Richard M. Stone |
| authorships[18].countries | US |
| authorships[18].affiliations[0].institution_ids | https://openalex.org/I4210117453 |
| authorships[18].affiliations[0].raw_affiliation_string | Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. |
| authorships[18].institutions[0].id | https://openalex.org/I4210117453 |
| authorships[18].institutions[0].ror | https://ror.org/02jzgtq86 |
| authorships[18].institutions[0].type | facility |
| authorships[18].institutions[0].lineage | https://openalex.org/I4210117453 |
| authorships[18].institutions[0].country_code | US |
| authorships[18].institutions[0].display_name | Dana-Farber Cancer Institute |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | Richard M Stone |
| authorships[18].is_corresponding | False |
| authorships[18].raw_affiliation_strings | Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. |
| authorships[19].author.id | https://openalex.org/A5017274457 |
| authorships[19].author.orcid | https://orcid.org/0000-0003-1390-6592 |
| authorships[19].author.display_name | George Giotopoulos |
| authorships[19].countries | GB |
| authorships[19].affiliations[0].institution_ids | https://openalex.org/I21196054, https://openalex.org/I241749 |
| authorships[19].affiliations[0].raw_affiliation_string | Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK. |
| authorships[19].affiliations[1].institution_ids | https://openalex.org/I241749 |
| authorships[19].affiliations[1].raw_affiliation_string | Department of Haematology, University of Cambridge, Cambridge, UK. |
| authorships[19].institutions[0].id | https://openalex.org/I241749 |
| authorships[19].institutions[0].ror | https://ror.org/013meh722 |
| authorships[19].institutions[0].type | education |
| authorships[19].institutions[0].lineage | https://openalex.org/I241749 |
| authorships[19].institutions[0].country_code | GB |
| authorships[19].institutions[0].display_name | University of Cambridge |
| authorships[19].institutions[1].id | https://openalex.org/I21196054 |
| authorships[19].institutions[1].ror | https://ror.org/05nz0zp31 |
| authorships[19].institutions[1].type | facility |
| authorships[19].institutions[1].lineage | https://openalex.org/I21196054, https://openalex.org/I241749, https://openalex.org/I4210087105, https://openalex.org/I87048295, https://openalex.org/I90344618 |
| authorships[19].institutions[1].country_code | GB |
| authorships[19].institutions[1].display_name | Wellcome/MRC Cambridge Stem Cell Institute |
| authorships[19].author_position | middle |
| authorships[19].raw_author_name | George Giotopoulos |
| authorships[19].is_corresponding | False |
| authorships[19].raw_affiliation_strings | Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Department of Haematology, University of Cambridge, Cambridge, UK. |
| authorships[20].author.id | https://openalex.org/A5029251605 |
| authorships[20].author.orcid | https://orcid.org/0000-0003-0312-161X |
| authorships[20].author.display_name | Brian J.P. Huntly |
| authorships[20].countries | GB |
| authorships[20].affiliations[0].institution_ids | https://openalex.org/I241749 |
| authorships[20].affiliations[0].raw_affiliation_string | Department of Haematology, University of Cambridge, Cambridge, UK. |
| authorships[20].affiliations[1].institution_ids | https://openalex.org/I21196054, https://openalex.org/I241749 |
| authorships[20].affiliations[1].raw_affiliation_string | Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK. |
| authorships[20].institutions[0].id | https://openalex.org/I241749 |
| authorships[20].institutions[0].ror | https://ror.org/013meh722 |
| authorships[20].institutions[0].type | education |
| authorships[20].institutions[0].lineage | https://openalex.org/I241749 |
| authorships[20].institutions[0].country_code | GB |
| authorships[20].institutions[0].display_name | University of Cambridge |
| authorships[20].institutions[1].id | https://openalex.org/I21196054 |
| authorships[20].institutions[1].ror | https://ror.org/05nz0zp31 |
| authorships[20].institutions[1].type | facility |
| authorships[20].institutions[1].lineage | https://openalex.org/I21196054, https://openalex.org/I241749, https://openalex.org/I4210087105, https://openalex.org/I87048295, https://openalex.org/I90344618 |
| authorships[20].institutions[1].country_code | GB |
| authorships[20].institutions[1].display_name | Wellcome/MRC Cambridge Stem Cell Institute |
| authorships[20].author_position | middle |
| authorships[20].raw_author_name | Brian J P Huntly |
| authorships[20].is_corresponding | False |
| authorships[20].raw_affiliation_strings | Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Department of Haematology, University of Cambridge, Cambridge, UK. |
| authorships[21].author.id | https://openalex.org/A5046985332 |
| authorships[21].author.orcid | https://orcid.org/0000-0002-5946-5238 |
| authorships[21].author.display_name | E. Joanna Baxter |
| authorships[21].countries | GB |
| authorships[21].affiliations[0].institution_ids | https://openalex.org/I241749 |
| authorships[21].affiliations[0].raw_affiliation_string | Department of Haematology, University of Cambridge, Cambridge, UK. |
| authorships[21].institutions[0].id | https://openalex.org/I241749 |
| authorships[21].institutions[0].ror | https://ror.org/013meh722 |
| authorships[21].institutions[0].type | education |
| authorships[21].institutions[0].lineage | https://openalex.org/I241749 |
| authorships[21].institutions[0].country_code | GB |
| authorships[21].institutions[0].display_name | University of Cambridge |
| authorships[21].author_position | middle |
| authorships[21].raw_author_name | Joanna Baxter |
| authorships[21].is_corresponding | False |
| authorships[21].raw_affiliation_strings | Department of Haematology, University of Cambridge, Cambridge, UK. |
| authorships[22].author.id | https://openalex.org/A5020700010 |
| authorships[22].author.orcid | https://orcid.org/0000-0002-5630-5909 |
| authorships[22].author.display_name | Fernando D. Camargo |
| authorships[22].countries | US |
| authorships[22].affiliations[0].institution_ids | https://openalex.org/I1288882113 |
| authorships[22].affiliations[0].raw_affiliation_string | Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA. |
| authorships[22].institutions[0].id | https://openalex.org/I1288882113 |
| authorships[22].institutions[0].ror | https://ror.org/00dvg7y05 |
| authorships[22].institutions[0].type | healthcare |
| authorships[22].institutions[0].lineage | https://openalex.org/I1288882113 |
| authorships[22].institutions[0].country_code | US |
| authorships[22].institutions[0].display_name | Boston Children's Hospital |
| authorships[22].author_position | middle |
| authorships[22].raw_author_name | Fernando Camargo |
| authorships[22].is_corresponding | False |
| authorships[22].raw_affiliation_strings | Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA. |
| authorships[23].author.id | https://openalex.org/A5100454210 |
| authorships[23].author.orcid | https://orcid.org/0000-0003-3307-1975 |
| authorships[23].author.display_name | Jie Liu |
| authorships[23].countries | US |
| authorships[23].affiliations[0].institution_ids | https://openalex.org/I194456095 |
| authorships[23].affiliations[0].raw_affiliation_string | Institute for Stem Cell Biology and Regenerative Medicine, Stanford, CA, USA. |
| authorships[23].institutions[0].id | https://openalex.org/I194456095 |
| authorships[23].institutions[0].ror | https://ror.org/033m8b439 |
| authorships[23].institutions[0].type | government |
| authorships[23].institutions[0].lineage | https://openalex.org/I194456095 |
| authorships[23].institutions[0].country_code | US |
| authorships[23].institutions[0].display_name | California Institute for Regenerative Medicine |
| authorships[23].author_position | middle |
| authorships[23].raw_author_name | Jie Liu |
| authorships[23].is_corresponding | False |
| authorships[23].raw_affiliation_strings | Institute for Stem Cell Biology and Regenerative Medicine, Stanford, CA, USA. |
| authorships[24].author.id | https://openalex.org/A5065154963 |
| authorships[24].author.orcid | https://orcid.org/0000-0002-8938-9889 |
| authorships[24].author.display_name | Balyn W. Zaro |
| authorships[24].countries | US |
| authorships[24].affiliations[0].institution_ids | https://openalex.org/I180670191 |
| authorships[24].affiliations[0].raw_affiliation_string | Department of Pharmaceutical Chemistry, Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA, USA. |
| authorships[24].institutions[0].id | https://openalex.org/I180670191 |
| authorships[24].institutions[0].ror | https://ror.org/043mz5j54 |
| authorships[24].institutions[0].type | education |
| authorships[24].institutions[0].lineage | https://openalex.org/I180670191 |
| authorships[24].institutions[0].country_code | US |
| authorships[24].institutions[0].display_name | University of California, San Francisco |
| authorships[24].author_position | middle |
| authorships[24].raw_author_name | Balyn W Zaro |
| authorships[24].is_corresponding | False |
| authorships[24].raw_affiliation_strings | Department of Pharmaceutical Chemistry, Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA, USA. |
| authorships[25].author.id | https://openalex.org/A5024724352 |
| authorships[25].author.orcid | https://orcid.org/0000-0003-4337-8022 |
| authorships[25].author.display_name | George S. Vassiliou |
| authorships[25].countries | GB |
| authorships[25].affiliations[0].institution_ids | https://openalex.org/I241749 |
| authorships[25].affiliations[0].raw_affiliation_string | Department of Haematology, University of Cambridge, Cambridge, UK. |
| authorships[25].affiliations[1].institution_ids | https://openalex.org/I21196054, https://openalex.org/I241749 |
| authorships[25].affiliations[1].raw_affiliation_string | Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK. |
| authorships[25].institutions[0].id | https://openalex.org/I241749 |
| authorships[25].institutions[0].ror | https://ror.org/013meh722 |
| authorships[25].institutions[0].type | education |
| authorships[25].institutions[0].lineage | https://openalex.org/I241749 |
| authorships[25].institutions[0].country_code | GB |
| authorships[25].institutions[0].display_name | University of Cambridge |
| authorships[25].institutions[1].id | https://openalex.org/I21196054 |
| authorships[25].institutions[1].ror | https://ror.org/05nz0zp31 |
| authorships[25].institutions[1].type | facility |
| authorships[25].institutions[1].lineage | https://openalex.org/I21196054, https://openalex.org/I241749, https://openalex.org/I4210087105, https://openalex.org/I87048295, https://openalex.org/I90344618 |
| authorships[25].institutions[1].country_code | GB |
| authorships[25].institutions[1].display_name | Wellcome/MRC Cambridge Stem Cell Institute |
| authorships[25].author_position | middle |
| authorships[25].raw_author_name | George S Vassiliou |
| authorships[25].is_corresponding | False |
| authorships[25].raw_affiliation_strings | Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Department of Haematology, University of Cambridge, Cambridge, UK. |
| authorships[26].author.id | https://openalex.org/A5029639803 |
| authorships[26].author.orcid | https://orcid.org/0000-0003-1387-886X |
| authorships[26].author.display_name | Leonhard Möckl |
| authorships[26].countries | DE |
| authorships[26].affiliations[0].institution_ids | https://openalex.org/I181369854 |
| authorships[26].affiliations[0].raw_affiliation_string | Faculty of Medicine 1, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany. |
| authorships[26].affiliations[1].institution_ids | https://openalex.org/I4210110240 |
| authorships[26].affiliations[1].raw_affiliation_string | Max Planck Institute for the Science of Light, Erlangen, Germany. |
| authorships[26].affiliations[2].institution_ids | https://openalex.org/I181369854 |
| authorships[26].affiliations[2].raw_affiliation_string | Faculty of Sciences, Department of Physics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany. |
| authorships[26].institutions[0].id | https://openalex.org/I181369854 |
| authorships[26].institutions[0].ror | https://ror.org/00f7hpc57 |
| authorships[26].institutions[0].type | education |
| authorships[26].institutions[0].lineage | https://openalex.org/I181369854 |
| authorships[26].institutions[0].country_code | DE |
| authorships[26].institutions[0].display_name | Friedrich-Alexander-Universität Erlangen-Nürnberg |
| authorships[26].institutions[1].id | https://openalex.org/I4210110240 |
| authorships[26].institutions[1].ror | https://ror.org/020as7681 |
| authorships[26].institutions[1].type | facility |
| authorships[26].institutions[1].lineage | https://openalex.org/I149899117, https://openalex.org/I4210110240 |
| authorships[26].institutions[1].country_code | DE |
| authorships[26].institutions[1].display_name | Max Planck Institute for the Science of Light |
| authorships[26].author_position | middle |
| authorships[26].raw_author_name | Leonhard Möckl |
| authorships[26].is_corresponding | False |
| authorships[26].raw_affiliation_strings | Faculty of Medicine 1, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Faculty of Sciences, Department of Physics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Max Planck Institute for the Science of Light, Erlangen, Germany. |
| authorships[27].author.id | https://openalex.org/A5055010244 |
| authorships[27].author.orcid | https://orcid.org/0000-0002-0201-2078 |
| authorships[27].author.display_name | Jorge de la Rosa |
| authorships[27].countries | GB |
| authorships[27].affiliations[0].institution_ids | https://openalex.org/I241749 |
| authorships[27].affiliations[0].raw_affiliation_string | Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, UK. |
| authorships[27].affiliations[1].raw_affiliation_string | Cambridge Institute of Science, Altos Labs, Cambridge, UK. |
| authorships[27].institutions[0].id | https://openalex.org/I241749 |
| authorships[27].institutions[0].ror | https://ror.org/013meh722 |
| authorships[27].institutions[0].type | education |
| authorships[27].institutions[0].lineage | https://openalex.org/I241749 |
| authorships[27].institutions[0].country_code | GB |
| authorships[27].institutions[0].display_name | University of Cambridge |
| authorships[27].author_position | middle |
| authorships[27].raw_author_name | Jorge de la Rosa |
| authorships[27].is_corresponding | False |
| authorships[27].raw_affiliation_strings | Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, UK., Cambridge Institute of Science, Altos Labs, Cambridge, UK. |
| authorships[28].author.id | https://openalex.org/A5082224298 |
| authorships[28].author.orcid | https://orcid.org/0000-0001-5013-0442 |
| authorships[28].author.display_name | Ryan A. Flynn |
| authorships[28].countries | US |
| authorships[28].affiliations[0].institution_ids | https://openalex.org/I136199984 |
| authorships[28].affiliations[0].raw_affiliation_string | Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA. [email protected]. |
| authorships[28].affiliations[1].institution_ids | https://openalex.org/I1288882113 |
| authorships[28].affiliations[1].raw_affiliation_string | Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA. [email protected]. |
| authorships[28].affiliations[2].institution_ids | https://openalex.org/I136199984, https://openalex.org/I4210157861 |
| authorships[28].affiliations[2].raw_affiliation_string | Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA. [email protected]. |
| authorships[28].institutions[0].id | https://openalex.org/I1288882113 |
| authorships[28].institutions[0].ror | https://ror.org/00dvg7y05 |
| authorships[28].institutions[0].type | healthcare |
| authorships[28].institutions[0].lineage | https://openalex.org/I1288882113 |
| authorships[28].institutions[0].country_code | US |
| authorships[28].institutions[0].display_name | Boston Children's Hospital |
| authorships[28].institutions[1].id | https://openalex.org/I4210157861 |
| authorships[28].institutions[1].ror | https://ror.org/04kj1hn59 |
| authorships[28].institutions[1].type | facility |
| authorships[28].institutions[1].lineage | https://openalex.org/I136199984, https://openalex.org/I4210157861 |
| authorships[28].institutions[1].country_code | US |
| authorships[28].institutions[1].display_name | Harvard Stem Cell Institute |
| authorships[28].institutions[2].id | https://openalex.org/I136199984 |
| authorships[28].institutions[2].ror | https://ror.org/03vek6s52 |
| authorships[28].institutions[2].type | education |
| authorships[28].institutions[2].lineage | https://openalex.org/I136199984 |
| authorships[28].institutions[2].country_code | US |
| authorships[28].institutions[2].display_name | Harvard University |
| authorships[28].author_position | middle |
| authorships[28].raw_author_name | Ryan A Flynn |
| authorships[28].is_corresponding | False |
| authorships[28].raw_affiliation_strings | Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA. [email protected]., Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA. [email protected]., Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA. [email protected]. |
| authorships[29].author.id | https://openalex.org/A5002638060 |
| authorships[29].author.orcid | https://orcid.org/0000-0002-4865-7648 |
| authorships[29].author.display_name | Konstantinos Tzelepis |
| authorships[29].countries | GB |
| authorships[29].affiliations[0].institution_ids | https://openalex.org/I21196054, https://openalex.org/I241749 |
| authorships[29].affiliations[0].raw_affiliation_string | Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK. [email protected]. |
| authorships[29].affiliations[1].institution_ids | https://openalex.org/I241749 |
| authorships[29].affiliations[1].raw_affiliation_string | Milner Therapeutics Institute, University of Cambridge, Cambridge, UK. [email protected]. |
| authorships[29].affiliations[2].institution_ids | https://openalex.org/I2802476451 |
| authorships[29].affiliations[2].raw_affiliation_string | Wellcome Trust Sanger Institute, Hinxton, UK. [email protected]. |
| authorships[29].affiliations[3].institution_ids | https://openalex.org/I241749 |
| authorships[29].affiliations[3].raw_affiliation_string | Department of Haematology, University of Cambridge, Cambridge, UK. [email protected]. |
| authorships[29].institutions[0].id | https://openalex.org/I241749 |
| authorships[29].institutions[0].ror | https://ror.org/013meh722 |
| authorships[29].institutions[0].type | education |
| authorships[29].institutions[0].lineage | https://openalex.org/I241749 |
| authorships[29].institutions[0].country_code | GB |
| authorships[29].institutions[0].display_name | University of Cambridge |
| authorships[29].institutions[1].id | https://openalex.org/I2802476451 |
| authorships[29].institutions[1].ror | https://ror.org/05cy4wa09 |
| authorships[29].institutions[1].type | nonprofit |
| authorships[29].institutions[1].lineage | https://openalex.org/I2802476451, https://openalex.org/I87048295 |
| authorships[29].institutions[1].country_code | GB |
| authorships[29].institutions[1].display_name | Wellcome Sanger Institute |
| authorships[29].institutions[2].id | https://openalex.org/I21196054 |
| authorships[29].institutions[2].ror | https://ror.org/05nz0zp31 |
| authorships[29].institutions[2].type | facility |
| authorships[29].institutions[2].lineage | https://openalex.org/I21196054, https://openalex.org/I241749, https://openalex.org/I4210087105, https://openalex.org/I87048295, https://openalex.org/I90344618 |
| authorships[29].institutions[2].country_code | GB |
| authorships[29].institutions[2].display_name | Wellcome/MRC Cambridge Stem Cell Institute |
| authorships[29].author_position | last |
| authorships[29].raw_author_name | Konstantinos Tzelepis |
| authorships[29].is_corresponding | False |
| authorships[29].raw_affiliation_strings | Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK. [email protected]., Department of Haematology, University of Cambridge, Cambridge, UK. [email protected]., Milner Therapeutics Institute, University of Cambridge, Cambridge, UK. [email protected]., Wellcome Trust Sanger Institute, Hinxton, UK. [email protected]. |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.nature.com/articles/s41587-025-02648-2.pdf |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Treatment of acute myeloid leukemia models by targeting a cell surface RNA-binding protein |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10725 |
| primary_topic.field.id | https://openalex.org/fields/13 |
| primary_topic.field.display_name | Biochemistry, Genetics and Molecular Biology |
| primary_topic.score | 0.9994000196456909 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1312 |
| primary_topic.subfield.display_name | Molecular Biology |
| primary_topic.display_name | RNA Interference and Gene Delivery |
| related_works | https://openalex.org/W4386282361, https://openalex.org/W4392699018, https://openalex.org/W4391050559, https://openalex.org/W4392679596, https://openalex.org/W4386278002, https://openalex.org/W2161184668, https://openalex.org/W2121576596, https://openalex.org/W2787826327, https://openalex.org/W1902458417, https://openalex.org/W2012639655 |
| cited_by_count | 8 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 8 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1038/s41587-025-02648-2 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S106963461 |
| best_oa_location.source.issn | 1087-0156, 1546-1696 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 1087-0156 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Nature Biotechnology |
| best_oa_location.source.host_organization | https://openalex.org/P4310319908 |
| best_oa_location.source.host_organization_name | Nature Portfolio |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310319908, https://openalex.org/P4310319965 |
| best_oa_location.source.host_organization_lineage_names | Nature Portfolio, Springer Nature |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.nature.com/articles/s41587-025-02648-2.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Nature Biotechnology |
| best_oa_location.landing_page_url | https://doi.org/10.1038/s41587-025-02648-2 |
| primary_location.id | doi:10.1038/s41587-025-02648-2 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S106963461 |
| primary_location.source.issn | 1087-0156, 1546-1696 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 1087-0156 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Nature Biotechnology |
| primary_location.source.host_organization | https://openalex.org/P4310319908 |
| primary_location.source.host_organization_name | Nature Portfolio |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310319908, https://openalex.org/P4310319965 |
| primary_location.source.host_organization_lineage_names | Nature Portfolio, Springer Nature |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.nature.com/articles/s41587-025-02648-2.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Nature Biotechnology |
| primary_location.landing_page_url | https://doi.org/10.1038/s41587-025-02648-2 |
| publication_date | 2025-04-23 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W3082855561, https://openalex.org/W3156985612, https://openalex.org/W3135688349, https://openalex.org/W4323539126, https://openalex.org/W4211099837, https://openalex.org/W2739492614, https://openalex.org/W4213105197, https://openalex.org/W2137881702, https://openalex.org/W3093044015, https://openalex.org/W4310107625, https://openalex.org/W2952354682, https://openalex.org/W2805058565, https://openalex.org/W4380320004, https://openalex.org/W4229042668, https://openalex.org/W3163961872, https://openalex.org/W2037991649, https://openalex.org/W2029461987, https://openalex.org/W2152122711, https://openalex.org/W4387881122, https://openalex.org/W3102223894, https://openalex.org/W2131157723, https://openalex.org/W2014141207, https://openalex.org/W2511013437, https://openalex.org/W3162916603, https://openalex.org/W4401757355, https://openalex.org/W4386442366, https://openalex.org/W4408022388, https://openalex.org/W3092603045, https://openalex.org/W2120100063, https://openalex.org/W4220655882, https://openalex.org/W4362635502, https://openalex.org/W2957271680, https://openalex.org/W3161370740, https://openalex.org/W2750218280, https://openalex.org/W2533641274, https://openalex.org/W2134967635, https://openalex.org/W2147810684, https://openalex.org/W2290515360, https://openalex.org/W2088559280, https://openalex.org/W2019602238, https://openalex.org/W2811405063, https://openalex.org/W2946904796, https://openalex.org/W3045364226, https://openalex.org/W2113081116, https://openalex.org/W2109336877, https://openalex.org/W2006445674, https://openalex.org/W2318505509, https://openalex.org/W2004180374, https://openalex.org/W1993384605, https://openalex.org/W4225397863, https://openalex.org/W4324330071, https://openalex.org/W2715749014, https://openalex.org/W7075659646, https://openalex.org/W3015889007, https://openalex.org/W3110342152, https://openalex.org/W2073889874, https://openalex.org/W4318755006, https://openalex.org/W2785043177, https://openalex.org/W3192622360, https://openalex.org/W2255555283, https://openalex.org/W1484491816, https://openalex.org/W2013024514, https://openalex.org/W4376121554, https://openalex.org/W2120504118, https://openalex.org/W3174503497, https://openalex.org/W4319941687, https://openalex.org/W4225357274 |
| referenced_works_count | 67 |
| abstract_inverted_index.a | 13, 48, 54, 76, 108, 119, 137 |
| abstract_inverted_index.We | 36, 74, 101 |
| abstract_inverted_index.an | 41, 159 |
| abstract_inverted_index.as | 40, 136, 158 |
| abstract_inverted_index.by | 12 |
| abstract_inverted_index.in | 87, 107, 130 |
| abstract_inverted_index.is | 105 |
| abstract_inverted_index.of | 15, 50, 93 |
| abstract_inverted_index.on | 32, 47, 56, 61, 69, 111, 139 |
| abstract_inverted_index.or | 166 |
| abstract_inverted_index.to | 79 |
| abstract_inverted_index.we | 19, 58 |
| abstract_inverted_index.AML | 113 |
| abstract_inverted_index.Our | 142 |
| abstract_inverted_index.and | 7, 24, 63, 90, 115, 124, 129, 147 |
| abstract_inverted_index.are | 10 |
| abstract_inverted_index.but | 67 |
| abstract_inverted_index.for | 2, 122, 163 |
| abstract_inverted_index.its | 148 |
| abstract_inverted_index.may | 116, 156 |
| abstract_inverted_index.not | 68 |
| abstract_inverted_index.AML, | 57, 94 |
| abstract_inverted_index.AML. | 126 |
| abstract_inverted_index.Here | 18 |
| abstract_inverted_index.RNAs | 26 |
| abstract_inverted_index.With | 53 |
| abstract_inverted_index.also | 133 |
| abstract_inverted_index.cell | 34, 43, 167 |
| abstract_inverted_index.data | 143 |
| abstract_inverted_index.find | 102 |
| abstract_inverted_index.form | 28 |
| abstract_inverted_index.lack | 14 |
| abstract_inverted_index.stem | 65, 72 |
| abstract_inverted_index.that | 21, 103, 145 |
| abstract_inverted_index.vivo | 131 |
| abstract_inverted_index.work | 132 |
| abstract_inverted_index.(AML) | 6 |
| abstract_inverted_index.acute | 3 |
| abstract_inverted_index.cells | 66, 114 |
| abstract_inverted_index.class | 162 |
| abstract_inverted_index.focus | 55 |
| abstract_inverted_index.offer | 118 |
| abstract_inverted_index.other | 8 |
| abstract_inverted_index.serve | 157 |
| abstract_inverted_index.solid | 140 |
| abstract_inverted_index.tumor | 51 |
| abstract_inverted_index.which | 82 |
| abstract_inverted_index.(NPM1) | 39 |
| abstract_inverted_index.blasts | 62 |
| abstract_inverted_index.cancer | 33 |
| abstract_inverted_index.cells. | 73 |
| abstract_inverted_index.csNPM1 | 60, 104, 135, 146 |
| abstract_inverted_index.manner | 110 |
| abstract_inverted_index.models | 92 |
| abstract_inverted_index.normal | 70 |
| abstract_inverted_index.robust | 84 |
| abstract_inverted_index.target | 80, 138 |
| abstract_inverted_index.types. | 52 |
| abstract_inverted_index.(csRBP) | 154 |
| abstract_inverted_index.Surface | 127 |
| abstract_inverted_index.antigen | 161 |
| abstract_inverted_index.cancers | 9 |
| abstract_inverted_index.csNPM1, | 81 |
| abstract_inverted_index.develop | 75 |
| abstract_inverted_index.general | 120 |
| abstract_inverted_index.limited | 11 |
| abstract_inverted_index.myeloid | 4 |
| abstract_inverted_index.observe | 59 |
| abstract_inverted_index.primary | 112 |
| abstract_inverted_index.protein | 45, 153 |
| abstract_inverted_index.suggest | 144 |
| abstract_inverted_index.surface | 44, 151 |
| abstract_inverted_index.tumors. | 141 |
| abstract_inverted_index.variety | 49 |
| abstract_inverted_index.without | 98 |
| abstract_inverted_index.(csNPM1) | 46 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.abundant | 42 |
| abstract_inverted_index.activity | 86 |
| abstract_inverted_index.antibody | 78 |
| abstract_inverted_index.clusters | 155 |
| abstract_inverted_index.discover | 20 |
| abstract_inverted_index.exhibits | 83 |
| abstract_inverted_index.leukemia | 5 |
| abstract_inverted_index.leukemic | 64 |
| abstract_inverted_index.multiple | 88 |
| abstract_inverted_index.proteins | 23 |
| abstract_inverted_index.strategy | 121 |
| abstract_inverted_index.targets. | 17 |
| abstract_inverted_index.treating | 125 |
| abstract_inverted_index.detecting | 123 |
| abstract_inverted_index.expressed | 106 |
| abstract_inverted_index.including | 95 |
| abstract_inverted_index.organized | 30 |
| abstract_inverted_index.precisely | 29 |
| abstract_inverted_index.profiling | 128 |
| abstract_inverted_index.surfaces. | 35 |
| abstract_inverted_index.syngeneic | 89 |
| abstract_inverted_index.targeting | 165 |
| abstract_inverted_index.therefore | 117 |
| abstract_inverted_index.toxicity. | 100 |
| abstract_inverted_index.xenograft | 91 |
| abstract_inverted_index.anti-tumor | 85 |
| abstract_inverted_index.monoclonal | 77 |
| abstract_inverted_index.observable | 99 |
| abstract_inverted_index.(glycoRNAs) | 27 |
| abstract_inverted_index.RNA-binding | 22, 152 |
| abstract_inverted_index.alternative | 160 |
| abstract_inverted_index.demonstrate | 134 |
| abstract_inverted_index.nanodomains | 31 |
| abstract_inverted_index.neighboring | 149 |
| abstract_inverted_index.therapeutic | 164 |
| abstract_inverted_index.xenografts, | 97 |
| abstract_inverted_index.characterize | 37 |
| abstract_inverted_index.glycosylated | 25 |
| abstract_inverted_index.hematopoietic | 71 |
| abstract_inverted_index.nucleophosmin | 38 |
| abstract_inverted_index.tumor-specific | 16 |
| abstract_inverted_index.Immunotherapies | 1 |
| abstract_inverted_index.glycoRNA–cell | 150 |
| abstract_inverted_index.identification. | 168 |
| abstract_inverted_index.patient-derived | 96 |
| abstract_inverted_index.mutation-agnostic | 109 |
| cited_by_percentile_year.max | 99 |
| cited_by_percentile_year.min | 98 |
| countries_distinct_count | 3 |
| institutions_distinct_count | 30 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8100000023841858 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.98639649 |
| citation_normalized_percentile.is_in_top_1_percent | True |
| citation_normalized_percentile.is_in_top_10_percent | True |